Compare ARK Genomic Revolution ETF (ARKG) vs iShares 20 Plus Year Treasury Bond ETF (TLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares 20 Plus Year Treasury Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.64, while iShares 20 Plus Year Treasury Bond ETF trades at $84.25. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares 20 Plus Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | TLT | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $92.06 |
52-Week Low | $23.09 | $83.02 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
TLT, the iShares 20+ Year Treasury Bond ETF, trades at $84.47, showing minimal daily movement with a slight decline of 0.02%. Technical indicators signal a bearish trend, while recent news highlights investor comparisons with other bond ETFs amid fluctuating Treasury yields. The ETF maintains consistent dividend distributions, with recent payouts in 2026, but lacks disclosed fundamental ratios like P/E or ROE, focusing instead on its role in long-term U.S. government debt exposure.
The outlook for TLT hinges on interest rate trends and economic data, with potential gains if the Fed cuts rates but risks from persistent inflation or further hikes. Investor sentiment is mixed, weighing high yields against duration risk, making it sensitive to macroeconomic shifts rather than company-specific fundamentals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares 20 Plus Year Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Read more on TLT →
